Genovis AB (GENO) NPV

Sell:19.18 SEKBuy:19.32 SEKPrice increased0.48 SEK (2.54%)

Prices delayed by at least 15 minutes
Sell:19.18 SEK
Buy:19.32 SEK
Change:Price increased0.48 SEK (2.54%)
Deal now
Prices delayed by at least 15 minutes
Sell:19.18 SEK
Buy:19.32 SEK
Change:Price increased0.48 SEK (2.54%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open18.50 SEK
Previous close18.92 SEK
Market capSEK 1.25bn
P/E ratio66.34
Volume101,530
Dividend yield0.00%
EMS-

Company information

Genovis AB is a Sweden-based company engaged in the research and development, production and marketing of technologies and products for cellular research. The Company offers products within two product portfolios, ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue66.06m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsSEK 377.93m
Total liabilitiesSEK 106.41m
Net debt-SEK 90.11m

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.